Home
Hemodialysis with Outset Tablo Makes the New York
Times!
Fifty
years after passage of the Medicare ESRD Program, the community has
swung back around to patient choice, flexibility, and quality of
life—and home dialysis treatments fit the bill. From about 30% home
dialyzors, the US is back up to 14%. NxStage and now the Tablo are
leading the charge. Learn more about the Tablo in this article. https://www.nytimes.com/2022/11/10/business/home-dialysis-tablo-outset.html
Kidney Views Blog Topics: Join us for our weekly home dialysis blog. Click
here to subscribe to new post alerts. Tell us what YOU think—we welcome comments and
guest blog posts!
-
Permission to Thrive—Bonus: End-stage Renal Disease (ESRD)
11/10 – April McGraw, RN, CNN
-
Advance Care Planning, End of Life Decisions, & Religious Views on Stopping Dialysis
11/03 – Beth Witten, MSW, ACSW, LSCSW
-
The Value of Setting Goals
10/27 – Jennifer Ravert, RN
-
The Benefits of Dialyzing While You sleep
10/20 – Michelle Carver, BSN, RN, CNN
Each month, we gather recent research abstracts about home dialysis.
Visit our
Journal Watch
to learn more:
Featured Link: Fresenius VersiPD
Learn about the smallest, lightest (12 lbs!), quietest
connected PD cycler. The MEI team got to see it at ASN, and we are still
talking about it! https://fmcna.com/products/home-dialysis-equipment/versipd-cycler-system/
|